2A Biosciences
Biotechnology Research
New York, Ny, United States
9 employees
- Employees
- 9
- Contacts
- 2
- Emails
- 2
- Phones
- 2
2A Biosciences Overview
- Headquarters
- New York, Ny, United States
- Website
- www.2abiosci.com
- Industry
- Biotechnology Research
- Employees
- 9
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About 2A Biosciences
2A Biosciences is pioneering a new class of disease-modifying therapies by unlocking the regenerative and neuroprotective power of serotonin 2A receptors. Our proprietary small molecules are designed to precisely activate 5-HT2A receptors to drive reinnervation, neuroprotection, and inflammation resolution across neurodegenerative ocular and CNS diseases. By targeting upstream biology that governs mitochondrial dysfunction, oxidative stress, and neuroinflammation, our approach simultaneously engages multiple degenerative pathways to halt disease progression at the root while promoting neuronal growth and functional repair.
2A Biosciences Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 2
- 50.0% coverage
2A Biosciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Brian Schoenbaum | Entrepreneur - Advisor - Investor — | Austin, Texas, United States |
Email
Phone
|
| Edny Inui, Phd, Mba | Partner @ Palo Santo - Neuroscience |
View
|
|
| David Nichols | Director of Drug Discovery at 2 | Raleigh, North Carolina, United States |
Email
Phone
|
| David Langer | Founder & Managing Partner at Lionheart | San Francisco Bay Area, United States |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to 2A Biosciences
atai Life Sciences
Biotechnology Research
GH Research plc
Biotechnology Research
Lionheart Ventures
Venture Capital And Private Equity Principals
Gilgamesh Pharmaceuticals
Pharmaceutical Manufacturing
Xylo Bio
Biotechnology
Sensorium Therapeutics
Biotechnology Research
Noetic Fund
Venture Capital And Private Equity Principals
Terran Biosciences
Biotechnology Research
Psychedelic Alpha
Online Audio And Video Media
reMind
Media And Telecommunications